Genetic Counseling for Teratogen Exposure
- 1 June 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 67 (6) , 843-846
- https://doi.org/10.1097/00006250-198606000-00020
Abstract
A consecutive series of 200 patients referred for genetic counseling after teratogen exposure was evaluated. One hundred four patients (52%) has exposure to more than one potentially teratogenic agent. One-third of the patients had a positive family history for genetic disease and 10% were of advanced maternal age. Genetic counseling was altered for the majority of patients when all risk factors (age, family history, and multiple teratogen exposure) were considered. Failure to evaluate all aspects of potential risk results in incomplete counseling. The majority of patients (97%) elected to continue their pregnancies after complete counseling. Three of five pregnancy terminations resulted from exposure to documented human teratogens. Precise risk assessment for the teratogen-exposed patient requires thorough genetic counseling to maximize successful pregnancy outcome.This publication has 10 references indexed in Scilit:
- DETECTION OF RUBELLA-SPECIFIC IgM IN SUBCLINICAL RUBELLA REINFECTION IN PREGNANCYThe Lancet, 1985
- Prenatal detection of congenital malformations by ultrasonographyAmerican Journal of Obstetrics and Gynecology, 1985
- Vietnam veterans' risks for fathering babies with birth defectsJAMA, 1984
- GENETIC-COUNSELING BEFORE PRENATAL-DIAGNOSIS FOR ADVANCED MATERNAL AGE - AN IMPORTANT MEDICAL SAFEGUARD1983
- PRENATAL COUNSELING - A STATEWIDE TELEPHONE SERVICE1982
- EXPOSURE TO PRESCRIBED DRUGS IN PREGNANCY AND ASSOCIATION WITH CONGENITAL-MALFORMATIONS1981
- Gonadal Dysfunction in Patients Receiving Chemotherapy for CancerAnnals of Internal Medicine, 1980
- Safety of Therapy for Allergic Symptoms During PregnancyAnnals of Internal Medicine, 1978
- The extent and character of drug consumption during pregnancyJAMA, 1978
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976